Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-26 @ 4:26 AM
Study NCT ID:
NCT00079027
Status:
UNKNOWN
Last Update Posted:
2013-12-18
First Post:
2004-03-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
Sponsor:
University Hospital Birmingham
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000353298
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None